Similar articles

• Mitoxantrone.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1988 Jul 1;30(769):67-8. Med Lett Drugs Ther. 1988. PMID: 3380059 No abstract available.
• Mitozantrone.

  [No authors listed] [No authors listed] Drug Ther Bull. 1986 Sep 8;24(18):71-2. Drug Ther Bull. 1986. PMID: 3757795 No abstract available.
• [Introduction of a new anticancer drug, novantrone].

  Tsukagoshi S. Tsukagoshi S. Gan To Kagaku Ryoho. 1987 Nov;14(11):3163-72. Gan To Kagaku Ryoho. 1987. PMID: 3314715 Clinical Trial. Japanese.
• An overview of mitozantrone.

  Birchall LA, Bailey NP, Blackledge GR. Birchall LA, et al. Br J Clin Pract. 1991 Autumn;45(3):208-11. Br J Clin Pract. 1991. PMID: 1805919 Review. No abstract available.
• Mitoxantrone: mechanism of action, antitumor activity, pharmacokinetics, efficacy in the treatment of solid tumors and lymphomas, and toxicity.

  Lenk H, Müller U, Tanneberger S. Lenk H, et al. Anticancer Res. 1987 Nov-Dec;7(6):1257-64. Anticancer Res. 1987. PMID: 3327453 Review.